| Ligand class | Compounds | References |
| Endogenous agonists | 15d-PGJ2, | [122–125] | 13-Hydroxyoctadecadienoic acid (13-HODE), | [122] | 9-hydroxyoctadecadienoic acid (9-HODE), | [122] | 15-hydroxyeicosatetraenoic acid (15-HETE), | [123] | nitrolinoleic acid | [126] |
| Synthetic agonists | Pioglitazone, troglitazone, rosiglitazone, ciglitazone, TZD18, | [127–129] | JTT-501, CDDO, SB-219994, SB-219993, GW2331, GW0072, | [130–133] | 5-ASA, PAT5A, TAK-559, GW7845, GW1929, LG10074, | [122, 134–137] | indomethacin, ibuprofen, flufenamic acid, conjugated linoleic acid, | [123, 138–140] | L-764406, L-796449, LY-510929, LY-465608, AD-5061, AD-5075, | [141–144] | KRP-297/MK-0767, MCC555, ragaglitazar, farglitazar, diclofenac | [145–148] |
| Antagonists | GW9662, CDDO-Me, BADGE, PD068235, SR-202 | [149, 150] |
|
|